CA Stock MarketDetailed Quotes

TBP Tetra Bio Pharma Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Sep 8 09:30 ET
10.58MMarket Cap-0.31P/E (TTM)

Tetra Bio Pharma Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2022
(Q2)May 31, 2022
(Q1)Feb 28, 2022
(FY)Nov 30, 2021
(Q4)Nov 30, 2021
(Q3)Aug 31, 2021
(Q2)May 31, 2021
(Q1)Feb 28, 2021
(FY)Nov 30, 2020
(Q4)Nov 30, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-40.21%3.42M
-49.30%3.26M
-57.26%3.59M
18.73%24.3M
-35.64%4.64M
18.40%5.72M
45.38%6.43M
84.39%8.39M
58.07%20.46M
125.13%7.21M
Selling and administrative expenses
-51.73%1.57M
-43.69%2.12M
-54.39%1.94M
39.58%12.25M
-13.48%1.86M
88.04%3.26M
49.31%3.77M
47.93%4.25M
30.56%8.77M
3.78%2.15M
-General and administrative expense
-51.73%1.57M
-43.69%2.12M
-54.39%1.94M
39.58%12.25M
-13.48%1.86M
88.04%3.26M
49.31%3.77M
47.93%4.25M
30.56%8.77M
3.78%2.15M
Research and development costs
-25.05%1.83M
-57.55%1.11M
-60.58%1.63M
2.43%11.94M
-45.65%2.75M
-21.17%2.44M
41.12%2.62M
146.83%4.13M
88.02%11.65M
356.91%5.06M
Depreciation amortization depletion
-17.77%21.94K
-34.08%21.94K
36.19%21.94K
225.57%111.95K
275.49%35.89K
209.39%26.68K
-9.65%33.28K
120.25%16.11K
25.11%34.39K
-65.22%9.56K
-Depreciation and amortization
-17.77%21.94K
-34.08%21.94K
36.19%21.94K
225.57%111.95K
275.49%35.89K
209.39%26.68K
-9.65%33.28K
120.25%16.11K
25.11%34.39K
-65.22%9.56K
Operating profit
40.21%-3.42M
49.30%-3.26M
57.26%-3.59M
-18.73%-24.3M
35.64%-4.64M
-18.40%-5.72M
-45.38%-6.43M
-84.39%-8.39M
-58.07%-20.46M
-125.13%-7.21M
Net non-operating interest income (expenses)
25.82%-99.57K
83.55%-107.01K
-137.4K
-1,926.83%-1.79M
-585.65%-114.2K
-851.20%-134.23K
-2,922.33%-650.52K
0
9.19%98.01K
141.76%23.52K
Non-operating interest income
-82.36%1.94K
-95.52%2.8K
--2.3K
7.15%105.03K
34.45%31.62K
-38.61%10.97K
170.90%62.44K
--0
9.19%98.01K
141.76%23.52K
Non-operating interest expense
-30.10%101.5K
-84.60%109.8K
--139.7K
--1.9M
--145.82K
--145.2K
--712.96K
--0
--0
----
Other net income (expenses)
-61.43%32.37K
55.44%-351.18K
4,610.34%2.1M
-3,204.88%-26.09M
-17,768.04%-25.43M
115.06%83.93K
-908.03%-788.1K
478.64%44.57K
-250.91%-789.42K
-324.24%-142.32K
Gain on sale of security
-166.46%-146.61K
90.29%-76.53K
-70.40%67K
-271.27%-1.46M
-410.91%-1.32M
496.03%220.59K
-1,055.66%-788.1K
2,022.67%226.34K
-74.77%-393.18K
-505.73%-257.52K
Special income (charges)
----
----
----
-5,951.53%-23.98M
----
----
----
----
---396.24K
--0
-Less:Impairment of capital assets
----
----
----
--23.98M
----
----
----
----
--0
----
-Less:Write off
----
----
----
--0
----
----
----
----
--396.24K
--0
Other non-operating income (expenses)
--178.98K
--200K
--2.17M
----
----
----
----
----
----
----
Income before tax
39.56%-3.49M
52.75%-3.72M
80.53%-1.63M
-146.65%-52.18M
-311.71%-30.19M
-7.46%-5.77M
-75.73%-7.86M
-84.30%-8.35M
-61.72%-21.15M
-129.35%-7.33M
Income tax
Earnings from equity interest net of tax
Net income
39.56%-3.49M
52.75%-3.72M
80.53%-1.63M
-97.06%-52.18M
-160.67%-30.19M
11.81%-5.77M
-67.47%-7.86M
-128.65%-8.35M
-73.24%-26.48M
-155.79%-11.58M
Net income continuous operations
39.56%-3.49M
52.75%-3.72M
80.53%-1.63M
-146.65%-52.18M
-311.71%-30.19M
-7.46%-5.77M
-75.73%-7.86M
-84.30%-8.35M
-61.72%-21.15M
-129.35%-7.33M
Net income discontinuous operations
----
----
----
--0
----
----
----
----
-141.68%-5.32M
-219.31%-4.25M
Noncontrolling interests
Net income attributable to the company
39.56%-3.49M
52.75%-3.72M
80.53%-1.63M
-97.06%-52.18M
-160.67%-30.19M
11.81%-5.77M
-67.47%-7.86M
-128.65%-8.35M
-73.24%-26.48M
-155.79%-11.58M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
39.56%-3.49M
52.75%-3.72M
80.53%-1.63M
-97.06%-52.18M
-160.67%-30.19M
11.81%-5.77M
-67.47%-7.86M
-128.65%-8.35M
-73.24%-26.48M
-155.79%-11.58M
Diluted earnings per share
0.00%-0.01
50.00%-0.01
86.67%-0.004
-20.00%-0.12
-87.88%-0.0752
50.00%-0.01
0.00%-0.02
-50.00%-0.03
-25.00%-0.1
-33.33%-0.04
Basic earnings per share
0.00%-0.01
50.00%-0.01
86.67%-0.004
-20.00%-0.12
-87.88%-0.0752
50.00%-0.01
0.00%-0.02
-50.00%-0.03
-25.00%-0.1
-33.33%-0.04
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2022(Q2)May 31, 2022(Q1)Feb 28, 2022(FY)Nov 30, 2021(Q4)Nov 30, 2021(Q3)Aug 31, 2021(Q2)May 31, 2021(Q1)Feb 28, 2021(FY)Nov 30, 2020(Q4)Nov 30, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -40.21%3.42M-49.30%3.26M-57.26%3.59M18.73%24.3M-35.64%4.64M18.40%5.72M45.38%6.43M84.39%8.39M58.07%20.46M125.13%7.21M
Selling and administrative expenses -51.73%1.57M-43.69%2.12M-54.39%1.94M39.58%12.25M-13.48%1.86M88.04%3.26M49.31%3.77M47.93%4.25M30.56%8.77M3.78%2.15M
-General and administrative expense -51.73%1.57M-43.69%2.12M-54.39%1.94M39.58%12.25M-13.48%1.86M88.04%3.26M49.31%3.77M47.93%4.25M30.56%8.77M3.78%2.15M
Research and development costs -25.05%1.83M-57.55%1.11M-60.58%1.63M2.43%11.94M-45.65%2.75M-21.17%2.44M41.12%2.62M146.83%4.13M88.02%11.65M356.91%5.06M
Depreciation amortization depletion -17.77%21.94K-34.08%21.94K36.19%21.94K225.57%111.95K275.49%35.89K209.39%26.68K-9.65%33.28K120.25%16.11K25.11%34.39K-65.22%9.56K
-Depreciation and amortization -17.77%21.94K-34.08%21.94K36.19%21.94K225.57%111.95K275.49%35.89K209.39%26.68K-9.65%33.28K120.25%16.11K25.11%34.39K-65.22%9.56K
Operating profit 40.21%-3.42M49.30%-3.26M57.26%-3.59M-18.73%-24.3M35.64%-4.64M-18.40%-5.72M-45.38%-6.43M-84.39%-8.39M-58.07%-20.46M-125.13%-7.21M
Net non-operating interest income (expenses) 25.82%-99.57K83.55%-107.01K-137.4K-1,926.83%-1.79M-585.65%-114.2K-851.20%-134.23K-2,922.33%-650.52K09.19%98.01K141.76%23.52K
Non-operating interest income -82.36%1.94K-95.52%2.8K--2.3K7.15%105.03K34.45%31.62K-38.61%10.97K170.90%62.44K--09.19%98.01K141.76%23.52K
Non-operating interest expense -30.10%101.5K-84.60%109.8K--139.7K--1.9M--145.82K--145.2K--712.96K--0--0----
Other net income (expenses) -61.43%32.37K55.44%-351.18K4,610.34%2.1M-3,204.88%-26.09M-17,768.04%-25.43M115.06%83.93K-908.03%-788.1K478.64%44.57K-250.91%-789.42K-324.24%-142.32K
Gain on sale of security -166.46%-146.61K90.29%-76.53K-70.40%67K-271.27%-1.46M-410.91%-1.32M496.03%220.59K-1,055.66%-788.1K2,022.67%226.34K-74.77%-393.18K-505.73%-257.52K
Special income (charges) -------------5,951.53%-23.98M-------------------396.24K--0
-Less:Impairment of capital assets --------------23.98M------------------0----
-Less:Write off --------------0------------------396.24K--0
Other non-operating income (expenses) --178.98K--200K--2.17M----------------------------
Income before tax 39.56%-3.49M52.75%-3.72M80.53%-1.63M-146.65%-52.18M-311.71%-30.19M-7.46%-5.77M-75.73%-7.86M-84.30%-8.35M-61.72%-21.15M-129.35%-7.33M
Income tax
Earnings from equity interest net of tax
Net income 39.56%-3.49M52.75%-3.72M80.53%-1.63M-97.06%-52.18M-160.67%-30.19M11.81%-5.77M-67.47%-7.86M-128.65%-8.35M-73.24%-26.48M-155.79%-11.58M
Net income continuous operations 39.56%-3.49M52.75%-3.72M80.53%-1.63M-146.65%-52.18M-311.71%-30.19M-7.46%-5.77M-75.73%-7.86M-84.30%-8.35M-61.72%-21.15M-129.35%-7.33M
Net income discontinuous operations --------------0-----------------141.68%-5.32M-219.31%-4.25M
Noncontrolling interests
Net income attributable to the company 39.56%-3.49M52.75%-3.72M80.53%-1.63M-97.06%-52.18M-160.67%-30.19M11.81%-5.77M-67.47%-7.86M-128.65%-8.35M-73.24%-26.48M-155.79%-11.58M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 39.56%-3.49M52.75%-3.72M80.53%-1.63M-97.06%-52.18M-160.67%-30.19M11.81%-5.77M-67.47%-7.86M-128.65%-8.35M-73.24%-26.48M-155.79%-11.58M
Diluted earnings per share 0.00%-0.0150.00%-0.0186.67%-0.004-20.00%-0.12-87.88%-0.075250.00%-0.010.00%-0.02-50.00%-0.03-25.00%-0.1-33.33%-0.04
Basic earnings per share 0.00%-0.0150.00%-0.0186.67%-0.004-20.00%-0.12-87.88%-0.075250.00%-0.010.00%-0.02-50.00%-0.03-25.00%-0.1-33.33%-0.04
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.